Infliximab for severe colitis associated with nivolumab followed by ipilimumab.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1111/1346-8138.14034

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.